What Happened?
Wayne, AK-based NFlection-Therapeutics Appointed William Hodder as Chief Executive Officer
About the Company
NFlection is a biopharmaceutical company focused on the development of novel therapies to address the needs of patients with neurofibromatosis type 1, immunosuppressant-mediated squamous cell carcinoma, and congenital birthmarks such as keratinocytic epidermal nevi and nevus sebaceous.
About the Person
William Hodder is Chief Executive Officer at NFlection Therapeutics. Previously, William held various senior HR leadership roles in the industry.
Info Source
News
Short Profile